Skip to main content

Table 4 Correlation of HER-2 expression and MMR status in 2031 GC patients

From: Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer

Variables p-MMR d-MMR p value
HER-2 3+ 75/2031 (3.7%) 2/2031 (0.1%) 0.129
HER-2 0/1+/2+ 1816/2031 (89.4%) 138/2031 (6.8%)